Discovery of a Highly Potent and Selective BRD9 PROTAC Degrader Based on E3 Binder Investigation for the Treatment of Hematological Tumors.
Duan H, Zhang J, Gui R, Lu Y, Pang A, Chen B, Shen L, Yu H, Li J, Xu T, Wang Y, Yao X, Zhang B, Lin N, Dong X, Zhou Y, Che J.
Duan H, et al. Among authors: zhang j.
J Med Chem. 2024 Jun 24. doi: 10.1021/acs.jmedchem.4c00883. Online ahead of print.
J Med Chem. 2024.
PMID: 38913763